
No Stock Yet
No Data
Green Leaf Pharmaceutical (02186.HK) issues 1.2 billion convertible bonds
Green Leaf Pharmaceutical (02186.HK) announcement, on July 27th, 2022, the company entered into a subscription agreement with the subscriber (Xinye Biopharmaceutical Holdings Co., Ltd.). According to the subscription agreement, the subscriber agrees to subscribe for corporate bonds with a principal amount of RMB 1.2 billion equivalent to Hong Kong dollars. All the prerequisites for the issue of corporate bonds set out in the subscription Agreement have been met. On August 16, 2022, the company issued corporate bonds with a total principal of 1.2 billion Hong Kong dollars to subscribers at the agreed exchange rate.
The more you fall, the more you buy! Valuation is close to the bottom of history, and the share of medical ETF has rebounded.
The agency said that in terms of the profitability and growth of the pharmaceutical industry as a whole, the boom has been continuing. From the valuation level, close to the bottom of history, it is attractive. On the whole, medicine has the attributes of both consumption and science and technology, and the current plate has an outstanding performance-to-price ratio.
Four departments: strengthen the monitoring of the shortage of drugs and the production and reserve of selected drugs in the centralized procurement of drugs organized by the state
Pride and Prejudice of innovative drugs: talking about "License-in" in controversy
Luye Pharma to Use Proceeds to Meet General Corporate Needs
Luye Pharma to Use Proceeds to Meet General Corporate Needs
Luye Pharma Group: Bonds Can Be Converted to Shares for HK$3.50/share
Luye Pharma Group: Bonds Can Be Converted to Shares for HK$3.50/share
Luye Pharma Group: Conversion Price Is at a 40% Premium to Last Traded Price of HK$2.50 Each
Luye Pharma Group: Conversion Price Is at a 40% Premium to Last Traded Price of HK$2.50 Each
Luye Pharma Group: Bonds if Converted Will Translate to 497.44M Shares
Luye Pharma Group: Bonds if Converted Will Translate to 497.44M Shares
Luye Pharma Group Seeks to Pay 6.50% Coupon on Convertible Bonds Due in One Year
Luye Pharma Group Seeks to Pay 6.50% Coupon on Convertible Bonds Due in One Year
Luye Pharma Group Seeks to Raise Up to CNY1.5B Issuing Convertible Bonds
Luye Pharma Group Seeks to Raise Up to CNY1.5B Issuing Convertible Bonds
Loading...
No Stock Yet